United Capital Financial Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

United Capital Financial Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-17,292	Closed	-$1.86M	–	1309
2016 Q4	$1.86M	Buy	17,292 +199	+1%	+$23.3K	0.02%	581
2016 Q3	$2.13M	Buy	17,093 +329	+2%	+$38.8K	0.02%	570
2016 Q2	$1.78M	Buy	16,764 +189	+1%	+$21.9K	0.02%	579
2016 Q1	$1.9M	Buy	+16,575	New	+$1.94M	0.02%	546

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

United Capital Financial Advisors's CBPO Position: Q1 2017 in Review

United Capital Financial Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 17,292 shares — an estimated $1.86M sold.

United Capital Financial Advisors first reported a position in CBPO in Q1 2016 and held it in 4 quarters. The position peaked at $2.13M in Q3 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

United Capital Financial Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
United Capital Financial Advisors sold 17,292 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $1.86M.
United Capital Financial Advisors first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 4 quarters.
United Capital Financial Advisors's China Biologic Products Holdings, Inc. position peaked at $2.13M in Q3 2016.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on United Capital Financial Advisors's 13F filing for Q1 2017, filed 12 May 2017.